Toggle Menu
Filings Insight
최근공시
Avalo Therapeutics, Inc.
0001534120 Nasdaq
SCHEDULE 13G/A - Avalo Therapeutics, Inc. (0001534120) (Subject)[0]
[SCHEDULE 13G/A]
(접수일: 2025-05-15)
[SUBJECT COMPANY]
Avalo Therapeutics, Inc. |
[FILED BY]
RA CAPITAL MANAGEMENT, L.P. |
/ 0